Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease

Primary location

Technische Universität München, Klinikum rechts der Isar, Klinik und Poliklinik für Neurologie

Munich, Germany

Contact

Paul Lingor, MD